APP and Alzheimer disease: An innovative microfluidic device constitutes the building block of a multi-organ platform, and a hydrogel-based 3D model of brain cells can be housed in the microfluidic device to facilitate the expression of APP and accumulate amyloid, which is related to AD pathology.